- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Prednisone fails to improve implantation failure in IVF patients: JAMA
Prednisone therapy did not increase live birth rate over placebo in patients with recurrent implantation failure, says an article published in the Journal of American Medical Association.
Failure to implant remains a significant obstacle to in vitro fertilization. Although there is insufficient evidence to support its effectiveness, prednisone is frequently used as an immune-regulatory agent to increase the likelihood of implantation and pregnancy. In order to assess the effectiveness of 10 mg of prednisone to a placebo on live birth among women who have experienced repeated implantation failure, Yun Sun and colleagues undertook this study.
This was a randomized, double-blind, placebo-controlled clinical investigation that was carried out at 8 Chinese reproductive clinics. Between November 2018 and August 2020, all eligible women who had a history of two or more failed embryo transfer cycles and who planned to undertake a frozen-thawed embryo transfer with the availability of high-quality embryos were recruited. From the day they began endometrial preparation for frozen-thawed embryo transfer through early pregnancy, participants were randomized (1:1) to receive oral pills containing either 10 mg of prednisone (n = 357) or a matching placebo (n = 358) once daily. The main result was a live birth, which is defined as the delivery of any number of neonates that were delivered at 28 weeks or more gestation and who were showing signs of life.
The key findings of this study were:
1. 714 (99.9%) of the 715 randomly assigned women (mean age: 32 years) had data on live birth outcomes, hence they were included in the main analysis.
2. In the prednisone group, live birth occurred in 37.8% of women (135 of 357) compared to 38.8% of women (139 of 358) in the placebo group.
3. In the prednisone group, the rate of biochemical pregnancy loss was 17.3%, compared to 9.9% in the placebo group.
4. Preterm births occurred in 5.5% of pregnancies in the placebo group and 11.8% of pregnancies in the prednisone group.
5. Rates of biochemical pregnancy, implantation, neonatal problems, congenital abnormalities, clinical pregnancy, other adverse events, and mean birthweights did not differ statistically significantly across groups.
In conclusion, prednisone usage may raise the risk of preterm birth and biochemical pregnancy loss, according to data. These findings call into question the efficacy of prednisone in treating recurrent implantation failure in clinical practice.
Reference:
Sun, Y., Cui, L., Lu, Y., Tan, J., Dong, X., Ni, T., Yan, J., Guan, Y., Hao, G., Liu, J.-Y., Zhang, B., Wei, D., Hong, Y., He, Y., Qi, J., Xu, B., Lu, J., Zhang, Q., Zhao, S., … Chen, Z. (2023). Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization. In JAMA (Vol. 329, Issue 17, p. 1460). American Medical Association (AMA). https://doi.org/10.1001/jama.2023.5302
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751